Drugs that contain Lenvatinib Mesylate

1. Drug name - LENVIMA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7253286 EISAI INC Nitrogen-containing aromatic derivatives
Oct, 2025

(3 years from now)

US7612208 EISAI INC Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same
Sep, 2026

(3 years from now)

US11186547 EISAI INC High-purity quinoline derivative and method for manufacturing same
Aug, 2035

(12 years from now)

US10407393 EISAI INC High-purity quinoline derivative and method for manufacturing same
Aug, 2035

(12 years from now)

US10259791 EISAI INC High-purity quinoline derivative and method for manufacturing same
Aug, 2035

(12 years from now)

CN101024627A EISAI INC Aromatic-Ring Derivative Including Nitrogen
Nov, 2010

(11 years ago)

CN101029022A EISAI INC Preparing Method Of Aromaticring Ramification Containing Nitrogen
Oct, 2021

(11 months ago)

CN1478078A EISAI INC Aromatic-Ring Derivative Including Nitrogen
Oct, 2021

(11 months ago)

CN1308310C EISAI INC Aromatic-Ring Derivative Including Nitrogen
Oct, 2021

(11 months ago)

CN101029022B EISAI INC Nitrogen-Containing Aromatic Ring Derivatives And Process For Their Preparation
Oct, 2021

(11 months ago)

CN101337931B EISAI INC Of Mesilate Of Acetic Acid Solvate Crystal (I) And Preparation Method Thereof
Dec, 2024

(2 years from now)

CN101337931A EISAI INC Mesilate And Acetic Acid To Object And Mesylate Is Crystal (I) And Its Preparation Method
Dec, 2024

(2 years from now)

CN101337933B EISAI INC Quinoline-Carboxamide Mesylate Crystal (A) And Its Preparation Method
Dec, 2024

(2 years from now)

CN101337933A EISAI INC Crystal (A) Of Mesilate Of Quinolinecarboxamide And Producing Method Thereof
Dec, 2024

(2 years from now)

CN100569753C EISAI INC 4 - (3 - (-4-(Cyclopropylaminocarbonyl) Aminophenoxy)--7 - Methoxy - -6 - Mesilate Of Crystal (C) And Preparation Method Thereof
Dec, 2024

(2 years from now)

CN101337932B EISAI INC Quinoline-Carboxamide Of Crystalline Form Of (B) And Its Preparation Method
Dec, 2024

(2 years from now)

CN1890220A EISAI INC A Crystalline Of The Salt Form Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Aminophenoxy)-7-Methoxy-6-Quinolinecarboxamide Or The Solvate Of The Salt And A Process For Preparing The Same
Dec, 2024

(2 years from now)

CN101337932A EISAI INC Crystal (B) Of Mesilate Of Quinolinecarboxamide And Producing Method Thereof
Dec, 2024

(2 years from now)

CN106660964A EISAI INC Quinoline Derivative With High Purity And Production Method Thereof
Aug, 2035

(12 years from now)

CN106660964B EISAI INC High Purity Quinoline Derivatives And Process For Producing The Same
Aug, 2035

(12 years from now)

IN236500B EISAI INC A Crystalline From Of The Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide
Dec, 2024

(2 years from now)

IN200602572P4 EISAI INC A Crystalline From Of The Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or The Solvate Of The Salt And A Process For Preparing The Same
Dec, 2024

(2 years from now)

EP1506962A2 EISAI INC Nitrogen-Containing Aromatic Heterocycles
Oct, 2021

(11 months ago)

EP1506962A3 EISAI INC Nitrogen-Containing Aromatic Heterocycles
Oct, 2021

(11 months ago)

EP1506962B1 EISAI INC Nitrogen-Containing Aromatic Heterocycles
Oct, 2021

(11 months ago)

EP1777218A1 EISAI INC Process For The Preparation Of 4-Phenoxy Quinoline Derivatives
Oct, 2021

(11 months ago)

EP1777218B1 EISAI INC Process For The Preparation Of 4-Phenoxy Quinoline Derivatives
Oct, 2021

(11 months ago)

EP1698623A1 EISAI INC Crystal Of Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or Of Solvate Thereof And Processes For Producing These
Dec, 2024

(2 years from now)

EP1698623B1 EISAI INC Crystal Of Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or Of Solvate Thereof And Processes For Producing These
Dec, 2024

(2 years from now)

EP1698623A4 EISAI INC Crystal Of Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or Of Solvate Thereof And Processes For Producing These
Dec, 2024

(2 years from now)

EP1415987A4 EISAI INC Nitrogenous Aromatic Ring Compounds
Oct, 2026

(4 years from now)

EP1415987A1 EISAI INC Nitrogenous Aromatic Ring Compounds As Anti Cancer Agents
Oct, 2026

(4 years from now)

EP1415987B1 EISAI INC Nitrogenous Aromatic Ring Compounds As Anti Cancer Agents
Oct, 2026

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9006256 EISAI INC Antitumor agent for thyroid cancer Jul, 2027

(4 years from now)

Treatment: Method for treating thyroid carcinoma including differentiated thyroid cancer

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 4MG BASE CAPSULE;ORAL Prescription
EQ 10MG BASE CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.